MedPath

PRALUENT

PRALUENT

Discontinued
DIN Number

02453762

Drug Class

Human

Market Date

Aug 13, 2016

Company
HC

sanofi-aventis canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02453762
AIG Number0158030002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription ,  Schedule D
A
ATC Code
C10AX14 ALIROCUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification24:06.24
Health Canada Classification

ACTIVE INGREDIENTS (1)

ALIROCUMABActive
Strength: 150 MG / ML
Monograph: ALIROCUMAB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.